Showing results (31-40 of 313) with videos related to
Sort By:
Pageof 32
Cancer|August 23, 2008
Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemiaSusan O'Brien, Deborah A Thomas, Farhad Ravandi, et al.Cancer|April 2, 2005
The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analogStefan Faderl, Varsha Gandhi, Michael J Keating, et al.Journal of Oncology Practice|March 12, 2015
Barriers to physician adherence to evidence-based monitoring guidelines in chronic myelogenous leukemiaStuart L Goldberg, Luke P Akard, Michael J Dugan, et al.Leukemia & Lymphoma|July 2, 2013
Fludarabine, cyclophosphamide and rituximab plus granulocyte macrophage colony-stimulating factor as frontline treatment for patients with chronic lymphocytic leukemiaPaolo Strati, Alessandra Ferrajoli, Susan Lerner, et al.Blood|December 24, 2005
Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemiaElihu Estey, Guillermo Garcia-Manero, Alessandra Ferrajoli, et al.Journal of Hematology & Oncology|October 27, 2022
Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by European LeukemiaNet 2017 risk subgroups in older adults with newly diagnosed, high-risk/secondary AML: post hoc analysis of a randomized, phase 3 trialJorge E Cortes, Tara L Lin, Kobby Asubonteng, et al.Cancer|July 17, 2008
The effect of interleukin 11 on thrombocytopenia associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemiaAhmed Aribi, Hagop Kantarjian, Charles Koller, et al.International Journal of Cancer|January 3, 2013
Is acute myeloid leukemia a liquid tumor?Maro Ohanian, Stefan Faderl, Farhad Ravandi, et al.International Journal of Hematology|April 3, 2009
Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experienceArturo Vega-Ruiz, Stefan Faderl, Zeev Estrov, et al.Cancer|March 29, 2002
Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemiaJorge Cortes, Deborah Thomas, Adan Rios, et al.Pageof 32